SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11377521
Source:
http://linkedlifedata.com/resource/pubmed/id/11377521
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023911
,
umls-concept:C0087111
,
umls-concept:C0205174
,
umls-concept:C0439858
,
umls-concept:C1554184
pubmed:issue
3
pubmed:dateCreated
2001-5-29
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0243532
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones
,
http://linkedlifedata.com/resource/pubmed/chemical/Azathioprine
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Muromonab-CD3
,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0041-1345
pubmed:author
pubmed-author:CastagnetoMM
,
pubmed-author:CavallariAA
,
pubmed-author:CilloUU
,
pubmed-author:FassatiL RLR
,
pubmed-author:FilipponiFF
,
pubmed-author:FortiDD
,
pubmed-author:GerundaG EGE
,
pubmed-author:RisalitiAA
,
pubmed-author:SalizzoniMM
,
pubmed-author:TisoneGG
,
pubmed-author:ValenteUU
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2258-62
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11377521-Adolescent
,
pubmed-meshheading:11377521-Adrenal Cortex Hormones
,
pubmed-meshheading:11377521-Adult
,
pubmed-meshheading:11377521-Aged
,
pubmed-meshheading:11377521-Azathioprine
,
pubmed-meshheading:11377521-Drug Therapy, Combination
,
pubmed-meshheading:11377521-Ethnic Groups
,
pubmed-meshheading:11377521-Female
,
pubmed-meshheading:11377521-Graft Rejection
,
pubmed-meshheading:11377521-Graft Survival
,
pubmed-meshheading:11377521-Humans
,
pubmed-meshheading:11377521-Immunosuppressive Agents
,
pubmed-meshheading:11377521-Liver Transplantation
,
pubmed-meshheading:11377521-Male
,
pubmed-meshheading:11377521-Middle Aged
,
pubmed-meshheading:11377521-Muromonab-CD3
,
pubmed-meshheading:11377521-Patient Selection
,
pubmed-meshheading:11377521-Reoperation
,
pubmed-meshheading:11377521-Safety
,
pubmed-meshheading:11377521-Survival Rate
,
pubmed-meshheading:11377521-Tacrolimus
,
pubmed-meshheading:11377521-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
pubmed:affiliation
Chirurgia Generale C, Ospedale S. Giovanni Battista di Torino, Italy.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study